The purpose of this study is to evaluate the feasibility and short-term safety and effectiveness of the NanoKnife™ System when used to ablate localized prostate cancer in low risk subjects with organ-confined prostate cancer and a low risk of recurrence. This study will evaluate the feasibility of the NanoKnife™ System as a focal therapy.